Kotak Healthcare Fund Regular-Growth
Mid CapEquity: Sectoral-Pharmaबहुत अधिक जोखिम
PaisaSmart रेटिंगअभी रेट नहीं किया गया
यह रेटिंग क्यों
This fund is not currently rated by our system. However, we continuously review and update our ratings, so it may be included in the future.
हमारा स्कोर दीर्घकालिक प्रदर्शन, जोखिम और निरंतरता को तौलता है — केवल पिछले रिटर्न को नहीं।
रिटर्न
8 Oct 2026 तक
1W
-2.21%
1M
-3.62%
3M
+3.75%
6M
+24.60%
9M
+22.61%
1Y
+22.85%
2Y
+9.15%
लॉन्च से अब तक
+19.24%
पोर्टफोलियो
31 Aug 2026 तक
मार्केट-कैप विभाजन
लार्ज कैप35.00%मिड कैप20.97%स्मॉल कैप44.03%
P/E
50.26
P/B
6.47
स्टाइल
Growth
सेक्टर आवंटन
Healthcare98.17%
Chemicals1.49%
होल्डिंग्स (36)
| होल्डिंग | फंड का % | मूल्य | शेयर |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 13.96% | ₹107.18 Cr | 5,40,000 |
| Divi's Laboratories Ltd. | 9.25% | ₹71 Cr | 75,000 |
| Torrent Pharmaceuticals Ltd. | 4.75% | ₹36.48 Cr | 72,000 |
| Molbio Diagnostics Ltd. | 4.53% | ₹34.76 Cr | 3,20,000 |
| Max Healthcare Institute Ltd. | 4.34% | ₹33.35 Cr | 3,20,000 |
| Acutaas Chemicals Ltd. | 3.91% | ₹30.03 Cr | 95,000 |
| Cipla Ltd. | 3.67% | ₹28.18 Cr | 2,00,000 |
| Park Medi World Ltd. | 3.36% | ₹25.79 Cr | 9,00,000 |
| Yatharth Hospital & Trauma Care Services Ltd. | 3.25% | ₹24.95 Cr | 2,49,000 |
| Apollo Hospitals Enterprise Ltd. | 3.25% | ₹24.92 Cr | 28,000 |
फंड विवरण
संक्षेप में
Long term capital growth. Investment in portfolio of predominantly equity & equity related securities of companies engaged in Pharma, Healthcare & allied sectors.
निवेश उद्देश्य
The scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly Pharma, Healthcare, and allied sectors.
एग्ज़िट लोड
0.5% for redemption within 30 Days
फंड प्रकार
Open-ended
न्यूनतम एकमुश्त
₹5,000
न्यूनतम निकासी
₹1,000
लॉक-इन
कोई नहीं
SIP
उपलब्ध
SWP
उपलब्ध
STP
उपलब्ध
खरीद कट-ऑफ
15:00